A citation-based method for searching scientific literature

Kajal Biswas, Ranabir Das, Julie M Eggington, Huanyu Qiao, Susan L North, Stacey Stauffer, Sandra S Burkett, Betty K Martin, Eileen Southon, Scott C Sizemore, Dmitry Pruss, Karla R Bowles, Benjamin B Roa, Neil Hunter, Lino Tessarollo, Richard J Wenstrup, R Andrew Byrd, Shyam K Sharan. Hum Mol Genet 2012
Times Cited: 39







List of co-cited articles
445 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Mouse embryonic stem cell-based functional assay to evaluate mutations in BRCA2.
Sergey G Kuznetsov, Pentao Liu, Shyam K Sharan. Nat Med 2008
91
46

A classification model for BRCA2 DNA binding domain missense variants based on homology-directed repair activity.
Lucia Guidugli, Vernon S Pankratz, Namit Singh, James Thompson, Catherine A Erding, Christoph Engel, Rita Schmutzler, Susan Domchek, Katherine Nathanson, Paolo Radice,[...]. Cancer Res 2013
71
43

Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2.
Bing Xia, Qing Sheng, Koji Nakanishi, Akihiro Ohashi, Jianmin Wu, Nicole Christ, Xinggang Liu, Maria Jasin, Fergus J Couch, David M Livingston. Mol Cell 2006
536
38

ENIGMA--evidence-based network for the interpretation of germline mutant alleles: an international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genes.
Amanda B Spurdle, Sue Healey, Andrew Devereau, Frans B L Hogervorst, Alvaro N A Monteiro, Katherine L Nathanson, Paolo Radice, Dominique Stoppa-Lyonnet, Sean Tavtigian, Barbara Wappenschmidt,[...]. Hum Mutat 2012
182
35

A review of a multifactorial probability-based model for classification of BRCA1 and BRCA2 variants of uncertain significance (VUS).
Noralane M Lindor, Lucia Guidugli, Xianshu Wang, Maxime P Vallée, Alvaro N A Monteiro, Sean Tavtigian, David E Goldgar, Fergus J Couch. Hum Mutat 2012
140
33

Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results.
Sharon E Plon, Diana M Eccles, Douglas Easton, William D Foulkes, Maurizio Genuardi, Marc S Greenblatt, Frans B L Hogervorst, Nicoline Hoogerbrugge, Amanda B Spurdle, Sean V Tavtigian. Hum Mutat 2008
548
33

Double-strand break repair-independent role for BRCA2 in blocking stalled replication fork degradation by MRE11.
Katharina Schlacher, Nicole Christ, Nicolas Siaud, Akinori Egashira, Hong Wu, Maria Jasin. Cell 2011
693
33

BRCA2 function in DNA binding and recombination from a BRCA2-DSS1-ssDNA structure.
Haijuan Yang, Philip D Jeffrey, Julie Miller, Elspeth Kinnucan, Yutong Sun, Nicolas H Thoma, Ning Zheng, Phang-Lang Chen, Wen-Hwa Lee, Nikola P Pavletich. Science 2002
494
33

Identification of the breast cancer susceptibility gene BRCA2.
R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, S Gregory, C Gumbs, G Micklem. Nature 1995
30

A comprehensive functional characterization of BRCA2 variants associated with Fanconi anemia using mouse ES cell-based assay.
Kajal Biswas, Ranabir Das, Blanche P Alter, Sergey G Kuznetsov, Stacey Stauffer, Susan L North, Sandra Burkett, Lawrence C Brody, Stefan Meyer, R Andrew Byrd,[...]. Blood 2011
34
32

A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes.
Douglas F Easton, Amie M Deffenbaugh, Dmitry Pruss, Cynthia Frye, Richard J Wenstrup, Kristina Allen-Brady, Sean V Tavtigian, Alvaro N A Monteiro, Edwin S Iversen, Fergus J Couch,[...]. Am J Hum Genet 2007
312
28

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy.
Hannah Farmer, Nuala McCabe, Christopher J Lord, Andrew N J Tutt, Damian A Johnson, Tobias B Richardson, Manuela Santarosa, Krystyna J Dillon, Ian Hickson, Charlotte Knights,[...]. Nature 2005
28

Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2.
S K Sharan, M Morimatsu, U Albrecht, D S Lim, E Regel, C Dinh, A Sands, G Eichele, P Hasty, A Bradley. Nature 1997
843
28

Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase.
Helen E Bryant, Niklas Schultz, Huw D Thomas, Kayan M Parker, Dan Flower, Elena Lopez, Suzanne Kyle, Mark Meuth, Nicola J Curtin, Thomas Helleday. Nature 2005
28

Functional assays for analysis of variants of uncertain significance in BRCA2.
Lucia Guidugli, Aura Carreira, Sandrine M Caputo, Asa Ehlen, Alvaro Galli, Alvaro N A Monteiro, Susan L Neuhausen, Thomas V O Hansen, Fergus J Couch, Maaike P G Vreeswijk. Hum Mutat 2014
69
28

Purified human BRCA2 stimulates RAD51-mediated recombination.
Ryan B Jensen, Aura Carreira, Stephen C Kowalczykowski. Nature 2010
410
25

PALB2 links BRCA1 and BRCA2 in the DNA-damage response.
Feng Zhang, Jianglin Ma, Jiaxue Wu, Lin Ye, Hong Cai, Bing Xia, Xiaochun Yu. Curr Biol 2009
328
25

BRCA2 is required for homology-directed repair of chromosomal breaks.
M E Moynahan, A J Pierce, M Jasin. Mol Cell 2001
689
25

Interactions between human BRCA2 protein and the meiosis-specific recombinase DMC1.
Tina Thorslund, Fumiko Esashi, Stephen C West. EMBO J 2007
77
23

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
23

Assessment of the Clinical Relevance of BRCA2 Missense Variants by Functional and Computational Approaches.
Lucia Guidugli, Hermela Shimelis, David L Masica, Vernon S Pankratz, Gary B Lipton, Namit Singh, Chunling Hu, Alvaro N A Monteiro, Noralane M Lindor, David E Goldgar,[...]. Am J Hum Genet 2018
34
26

Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2.
David E Goldgar, Douglas F Easton, Amie M Deffenbaugh, Alvaro N A Monteiro, Sean V Tavtigian, Fergus J Couch. Am J Hum Genet 2004
274
20

Two classes of BRC repeats in BRCA2 promote RAD51 nucleoprotein filament function by distinct mechanisms.
Aura Carreira, Stephen C Kowalczykowski. Proc Natl Acad Sci U S A 2011
94
20

Functional evaluation and cancer risk assessment of BRCA2 unclassified variants.
Kangjian Wu, Shannon R Hinson, Akihiro Ohashi, Daniel Farrugia, Patricia Wendt, Sean V Tavtigian, Amie Deffenbaugh, David Goldgar, Fergus J Couch. Cancer Res 2005
102
20

Structural basis for recruitment of BRCA2 by PALB2.
Antony W Oliver, Sally Swift, Christopher J Lord, Alan Ashworth, Laurence H Pearl. EMBO Rep 2009
115
20

Human BRCA2 protein promotes RAD51 filament formation on RPA-covered single-stranded DNA.
Jie Liu, Tammy Doty, Bryan Gibson, Wolf-Dietrich Heyer. Nat Struct Mol Biol 2010
244
20

The BRC repeats in BRCA2 are critical for RAD51 binding and resistance to methyl methanesulfonate treatment.
P L Chen, C F Chen, Y Chen, J Xiao, Z D Sharp, W H Lee. Proc Natl Acad Sci U S A 1998
310
20

BRCA1 R1699Q variant displaying ambiguous functional abrogation confers intermediate breast and ovarian cancer risk.
Amanda B Spurdle, Phillip J Whiley, Bryony Thompson, Bingjian Feng, Sue Healey, Melissa A Brown, Christopher Pettigrew, Christi J Van Asperen, Margreet G E M Ausems, Anna A Kattentidt-Mouravieva,[...]. J Med Genet 2012
66
20

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
803
20

BRCA2 localization to the midbody by filamin A regulates cep55 signaling and completion of cytokinesis.
Gourish Mondal, Matthew Rowley, Lucia Guidugli, Jianmin Wu, Vernon S Pankratz, Fergus J Couch. Dev Cell 2012
59
17

The breast cancer tumor suppressor BRCA2 promotes the specific targeting of RAD51 to single-stranded DNA.
Tina Thorslund, Michael J McIlwraith, Sarah A Compton, Sergey Lekomtsev, Mark Petronczki, Jack D Griffith, Stephen C West. Nat Struct Mol Biol 2010
166
17

Abnormal cytokinesis in cells deficient in the breast cancer susceptibility protein BRCA2.
Matthew J Daniels, Yunmei Wang, Miyoung Lee, Ashok R Venkitaraman. Science 2004
234
17

Biallelic inactivation of BRCA2 in Fanconi anemia.
Niall G Howlett, Toshiyasu Taniguchi, Susan Olson, Barbara Cox, Quinten Waisfisz, Christine De Die-Smulders, Nicole Persky, Markus Grompe, Hans Joenje, Gerard Pals,[...]. Science 2002
849
17



PALB2 functionally connects the breast cancer susceptibility proteins BRCA1 and BRCA2.
Fan Zhang, Qiang Fan, Keqin Ren, Paul R Andreassen. Mol Cancer Res 2009
186
17

Functional assays for classification of BRCA2 variants of uncertain significance.
Daniel J Farrugia, Mukesh K Agarwal, Vernon S Pankratz, Amie M Deffenbaugh, Dmitry Pruss, Cynthia Frye, Linda Wadum, Kiley Johnson, Jennifer Mentlick, Sean V Tavtigian,[...]. Cancer Res 2008
88
17

The BRC repeats of BRCA2 modulate the DNA-binding selectivity of RAD51.
Aura Carreira, Jovencio Hilario, Ichiro Amitani, Ronald J Baskin, Mahmud K K Shivji, Ashok R Venkitaraman, Stephen C Kowalczykowski. Cell 2009
160
17

A high-throughput functional complementation assay for classification of BRCA1 missense variants.
Peter Bouwman, Hanneke van der Gulden, Ingrid van der Heijden, Rinske Drost, Christiaan N Klijn, Pramudita Prasetyanti, Mark Pieterse, Ellen Wientjens, Jost Seibler, Frans B L Hogervorst,[...]. Cancer Discov 2013
78
17

Insights into DNA recombination from the structure of a RAD51-BRCA2 complex.
Luca Pellegrini, David S Yu, Thomas Lo, Shubha Anand, MiYoung Lee, Tom L Blundell, Ashok R Venkitaraman. Nature 2002
481
17

Stabilization of stalled DNA replication forks by the BRCA2 breast cancer susceptibility protein.
Mikhail Lomonosov, Shubha Anand, Mahesh Sangrithi, Rachel Davies, Ashok R Venkitaraman. Genes Dev 2003
182
17

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet Med 2015
17

Stabilization of RAD51 nucleoprotein filaments by the C-terminal region of BRCA2.
Fumiko Esashi, Vitold E Galkin, Xiong Yu, Edward H Egelman, Stephen C West. Nat Struct Mol Biol 2007
180
15

BRCA1 and BRCA2: different roles in a common pathway of genome protection.
Rohini Roy, Jarin Chun, Simon N Powell. Nat Rev Cancer 2011
695
15

A cancer-associated BRCA2 mutation reveals masked nuclear export signals controlling localization.
Anand D Jeyasekharan, Yang Liu, Hiroyoshi Hattori, Venkat Pisupati, Asta Bjork Jonsdottir, Eeson Rajendra, Miyoung Lee, Elayanambi Sundaramoorthy, Simon Schlachter, Clemens F Kaminski,[...]. Nat Struct Mol Biol 2013
61
15

BRCA2 is required for ionizing radiation-induced assembly of Rad51 complex in vivo.
S S Yuan, S Y Lee, G Chen, M Song, G E Tomlinson, E Y Lee. Cancer Res 1999
325
15

Resistance to therapy caused by intragenic deletion in BRCA2.
Stacey L Edwards, Rachel Brough, Christopher J Lord, Rachael Natrajan, Radost Vatcheva, Douglas A Levine, Jeff Boyd, Jorge S Reis-Filho, Alan Ashworth. Nature 2008
652
15

Cooperation of breast cancer proteins PALB2 and piccolo BRCA2 in stimulating homologous recombination.
Rémi Buisson, Anne-Marie Dion-Côté, Yan Coulombe, Hélène Launay, Hong Cai, Alicja Z Stasiak, Andrzej Stasiak, Bing Xia, Jean-Yves Masson. Nat Struct Mol Biol 2010
201
15


Breast-cancer risk in families with mutations in PALB2.
Antonis C Antoniou, Silvia Casadei, Tuomas Heikkinen, Daniel Barrowdale, Katri Pylkäs, Jonathan Roberts, Andrew Lee, Deepak Subramanian, Kim De Leeneer, Florentia Fostira,[...]. N Engl J Med 2014
477
15


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.